Duloxetine Capsule, Delayed Release Pellets
Product Images NDC 71335-1445

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 71335-1445). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

1 (Image 1)

1 (Image 1)
FDA Label Image

Figure6 (Image 10)

Figure6 (Image 10)
FDA Label Image

Figure8 (Image 11)

Figure8 (Image 11)
FDA Label Image

Figure9 (Image 12)

Figure9 (Image 12)
Percentage of Patients Improved: This text appears to be a chart or graph displaying the percentage of patients who have shown improvement. The graph has two groups labeled "Placebo" and "Duloxetine Delayed-Release 60 mg Once Daily." The x-axis appears to represent the percentage improvement in pain from baseline, ranging from 0 to 100. The y-axis shows the percentage of patients improved, ranging from 0 to 100. There are no specific values provided for each category, making it difficult to provide a detailed analysis.*
FDA Label Image

Figure10 (Image 13)

Figure10 (Image 13)
FDA Label Image

1 (Image 2)

1 (Image 2)
FDA Label Image

1 (Image 3)

1 (Image 3)
FDA Label Image

1 (Image 4)

1 (Image 4)
FDA Label Image

Figure1 (Image 5)

Figure1 (Image 5)
FDA Label Image

Figure2 (Image 6)

Figure2 (Image 6)
Not available.*
FDA Label Image

Figure3 (Image 7)

Figure3 (Image 7)
FDA Label Image

Figure4 (Image 8)

Figure4 (Image 8)
FDA Label Image

Figure5 (Image 9)

Figure5 (Image 9)
FDA Label Image

Label (Lbl713351445)

Label (Lbl713351445)
This text appears to be a description of a medication called Duloxetine Hydrochloride. The capsules contain 67.3 mg of Duloxetine and are delayed-release. Each capsule is equivalent to 60 mg of Duloxetine. The medication is to be stored at a temperature of 25°C (77°F) with excursions permitted to 15° to 30°C (59° to 86°F). It is important to keep this medication out of reach of children. The text also mentions that the medication should be dispensed in a tight, light-resistant container and that it is manufactured by Bryant Ranch Prepack, Inc and distributed by Actavis Pharma, Inc. It refers to a Medication Guide that should be provided to each patient. The full text contains a link to additional information about the medication on the FDA website, but the link appears to be cut off.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.